DKA mortality risk

The Diabetic ketoacidosis page has been updated to indicate that, if treated properly, DKA is no longer a condition associated with significant mortality risk.

Metformin

The Other hypoglycaemic agents page has been updated with additional information about metformin, particularly regarding its relative lack of benefits compared to newer agents.

DKA management

The Diabetic ketoacidosis page has had a few minor updates including greater emphasis on the lack of utility and probably increased risk of harm from initial bolus insulin (despite being included in some guidelines).